Poems syndrome: consolidation with autologous stem cell transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
https://www.nature.com/articles/s41409-021-01395-7.pdf
Reference13 articles.
1. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–506.
2. Dispenzieri A. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94:812–27. https://doi.org/10.1002/ajh.25495. Epub 2019 May 23.
3. Hogan WJ, Lacy MQ, Wiseman GA, Fealey RD, Dispenzieri A, Gertz MA. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transpl. 2001;28:305–9.
4. Cook G, Iacobelli S, van Biezen A, Ziagkos D, LeBlond V, Abraham J, et al. High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the plasma cell disorder sub-committee of the chronic malignancy working party of the European Society for Blood & Marrow Transplantation. Haematologica. 2017;102:160–7.
5. D’Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S, et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center Experience. Blood. 2012;120:56–62.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hematologic malignancies and hematopoietic stem cell transplantation;Handbook of Clinical Neurology;2024
2. A rare syndrome where our multidisciplinary approach significantly helped the patient;Neurologie pro praxi;2023-06-14
3. Daratumumab, Carfilzomib, Pomalidomide and Elotuzumab for the Treatment of POEMS Syndrome- The Mayo Clinic Experience;2022-12-19
4. Melphalan/prednisolone;Reactions Weekly;2022-05
5. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome;International Urology and Nephrology;2022-02-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3